Artwork

Innhold levert av Dr Jess. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Dr Jess eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

Low Dose Naltrexone and Chronic Illness. An Interview with Linda Elsegood

1:06:00
 
Del
 

Manage episode 152645509 series 1066460
Innhold levert av Dr Jess. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Dr Jess eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Looking over the last several shows, the base theme is chronic inflammation....Sooo, this week I decided to replay My interview with Linda Elsegood concerning LDN or Low Dose Naltrexone that being sucessfully utilized to treat numerous chronic illnesses. Linda Elsegood is a leader in the movement to educate patients and doctors about LDN. Her tireless effort is bringing healing to many. Linda Elsegood was diagnosed with MS in 2000 at the age of 44. She started LDN 3rd Deb 2003 and founded the LDN Research Trust in Feb 2004 to tell other people find out about LDN and to find prescribing doctors and to help and support clinical trials of LDN. She has organised several LDN conferences, the next being in 2016 in Orlando. She has offered our listners a discount on the conference and live streaming! $30 off a 3 day ticket using the code conf30, $15 off the live stream using the code live15 http://www.ldn2016.com/ Her ultimate goal is for everyone with an autoimmune disease to be given LDN as a first line treatment and in the UK to have it on the NHS. LDN isn't a cure and doesn't work for everyone but it is something well worth researching! This information is worth re-visiting....tell your friends!!!
  continue reading

85 episoder

Artwork
iconDel
 
Manage episode 152645509 series 1066460
Innhold levert av Dr Jess. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Dr Jess eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Looking over the last several shows, the base theme is chronic inflammation....Sooo, this week I decided to replay My interview with Linda Elsegood concerning LDN or Low Dose Naltrexone that being sucessfully utilized to treat numerous chronic illnesses. Linda Elsegood is a leader in the movement to educate patients and doctors about LDN. Her tireless effort is bringing healing to many. Linda Elsegood was diagnosed with MS in 2000 at the age of 44. She started LDN 3rd Deb 2003 and founded the LDN Research Trust in Feb 2004 to tell other people find out about LDN and to find prescribing doctors and to help and support clinical trials of LDN. She has organised several LDN conferences, the next being in 2016 in Orlando. She has offered our listners a discount on the conference and live streaming! $30 off a 3 day ticket using the code conf30, $15 off the live stream using the code live15 http://www.ldn2016.com/ Her ultimate goal is for everyone with an autoimmune disease to be given LDN as a first line treatment and in the UK to have it on the NHS. LDN isn't a cure and doesn't work for everyone but it is something well worth researching! This information is worth re-visiting....tell your friends!!!
  continue reading

85 episoder

Todos los episodios

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett